share_log

CureVac Announced The Latest Trial Dates For Its Ongoing Patent Litigation Against Pfizer/BioNTech In Multiple Geographies, Including The U.S., UK, And Germany

CureVac Announced The Latest Trial Dates For Its Ongoing Patent Litigation Against Pfizer/BioNTech In Multiple Geographies, Including The U.S., UK, And Germany

CureVac宣佈在多個地區（包括美國、英國和德國）對輝瑞/BioNTech正在進行的專利訴訟進行最新的審判日期
Benzinga ·  07/11 07:20

  • New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics.

  • First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent litigation

  • UK trial on validity of intellectual property rights EP 3 708 668 B1 and EP 4 023 755 B1 (split poly-A tail technology) began July 10; judgement expected later in 2024

  • 在與Acuitas Therapeutics達成和解後，美國專利訴訟的新審判日期定爲2025年3月3日。

  • 在德國專利訴訟背景下，歐洲專利局定於2025年3月25日對EP 3 708 668 B1（分體式Poly-A尾技術）的有效性作出一審裁決

  • 英國關於知識產權有效性的審判 EP 3 708 668 B1 和 EP 4 023 755 B1（拆分 Poly-A 尾翼技術）於 7 月 10 日開始；預計在 2024 年晚些時候作出判決

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論